Literature DB >> 17508917

Mechanisms for oxidative stress in diabetic cardiovascular disease.

Subramaniam Pennathur1, Jay W Heinecke.   

Abstract

Obesity, metabolic syndrome, and diabetes are increasingly prevalent in Western society, and they markedly increase the risk for atherosclerotic vascular disease, the major cause of death in diabetics. Although recent evidence suggests a causal role for oxidative stress in insulin resistance, diabetes, and atherosclerosis, there is considerable controversy regarding its nature, magnitude, and underlying mechanisms. Glucose promotes glycoxidation reactions in vitro, and products of glycoxidation and lipoxidation are elevated in plasma and tissue from humans suffering from diabetes, but the exact relationships between hyperglycemia and oxidative stress are poorly understood. This review focuses on molecular mechanisms of increased oxidative stress in diabetes, the relationship of oxidant production to hyperglycemia, and the potential interaction of reactive carbonyls and lipids in oxidant generation. Using highly sensitive and specific gas chromatography-mass spectrometry, molecular signatures of specific oxidation pathways were identified in tissues of diabetic humans and animals. These studies support the hypothesis that unique reactive intermediates generated in localized microenvironments of vulnerable tissues promote diabetic damage. Therapies interrupting these reactive pathways in vascular tissue might help prevent cardiovascular disease in this high-risk population.

Entities:  

Mesh:

Year:  2007        PMID: 17508917     DOI: 10.1089/ars.2007.1595

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  48 in total

1.  The reaction of HOCl and cyanocobalamin: corrin destruction and the liberation of cyanogen chloride.

Authors:  Husam M Abu-Soud; Dhiman Maitra; Jaeman Byun; Carlos Eduardo A Souza; Jashoman Banerjee; Ghassan M Saed; Michael P Diamond; Peter R Andreana; Subramaniam Pennathur
Journal:  Free Radic Biol Med       Date:  2011-11-10       Impact factor: 7.376

2.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

3.  Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.

Authors:  Robert L Wilensky; Yi Shi; Emile R Mohler; Damir Hamamdzic; Mark E Burgert; Jun Li; Anthony Postle; Robert S Fenning; James G Bollinger; Bryan E Hoffman; Daniel J Pelchovitz; Jisheng Yang; Rosanna C Mirabile; Christine L Webb; LeFeng Zhang; Ping Zhang; Michael H Gelb; Max C Walker; Andrew Zalewski; Colin H Macphee
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

4.  Structured lifestyle intervention in patients with the metabolic syndrome mitigates oxidative stress but fails to improve measures of cardiovascular autonomic neuropathy.

Authors:  Subramaniam Pennathur; Mamta Jaiswal; Anuradha Vivekanandan-Giri; Elizabeth A White; Lynn Ang; David M Raffel; Melvyn Rubenfire; Rodica Pop-Busui
Journal:  J Diabetes Complications       Date:  2017-05-02       Impact factor: 2.852

5.  Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.

Authors:  Paige S Katz; Aaron J Trask; Flavia M Souza-Smith; Kirk R Hutchinson; Maarten L Galantowicz; Kevin C Lord; James A Stewart; Mary J Cismowski; Kurt J Varner; Pamela A Lucchesi
Journal:  Basic Res Cardiol       Date:  2011-07-10       Impact factor: 17.165

6.  Improvement of diabetic or obese patients' erythrocyte deformability by the program of the brain-oriented obesity control system (BOOCS).

Authors:  K Saito; K Odashiro; T Maruyama; K Akashi; S Mawatari; T Fujino
Journal:  J Physiol Sci       Date:  2012-07-29       Impact factor: 2.781

7.  Tetrahydroindenoindole inhibits the progression of diabetes in mice.

Authors:  Howard G Shertzer; Scott N Schneider; Eric L Kendig; Deborah J Clegg; David A D'Alessio; Elisabet Johansson; Mary Beth Genter
Journal:  Chem Biol Interact       Date:  2008-09-07       Impact factor: 5.192

Review 8.  Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Exp Gerontol       Date:  2009-07-19       Impact factor: 4.032

9.  Decreased nitric oxide bioavailability in a mouse model of Fabry disease.

Authors:  Liming Shu; James L Park; Jaeman Byun; Subramaniam Pennathur; Jessica Kollmeyer; James A Shayman
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

Review 10.  Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders.

Authors:  Kelsey Fisher-Wellman; Heather K Bell; Richard J Bloomer
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.